Twist-ing cell fate: Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis

D. Cakouros, R. M. Raices, S. Gronthos, C. A. Glackin

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Bone marrow-derived mesenchymal stem cells (MSCs), are multipotent cells that give rise to multiple lineages including osteoblasts, adipocytes, muscle, and fibroblasts. MSCs are useful for clinical applications such as cell therapy because they can be isolated from an individual and expanded for use in tissue repair, as well as other therapeutic applications, without immune rejection. However, one of the key problems in the use of MSCs for these applications is the efficiency of these cells to engraft and fully regenerate damaged tissues. Therefore, to optimize this process, a comprehensive understanding of the key regulators of MSCs self-renewal and maintenance are critical to the success of future cell therapy as well as other clinical applications. The basic helix loop helix transcription factor, Twist, plays a master regulatory role in all of these processes and, therefore, a thorough understanding of the mechanistic insights in the role of Twist in lineage specification/differentiation and tumorigenesis is vital to the success of future clinical applications for the therapeutic use of MSCs. In this article, we highlight the basic mechanisms and signaling pathways that are important to MSC fate, maintenance, and differentiation, as well as the critical role that Twist plays in these processes. In addition, we review the known literature suggesting a critical role for Twist in the generation of cancer stem cells, as this information may contribute to a broader understanding of stem cell biology and stem-cell-based therapeutics.

LanguageEnglish
Pages1288-1298
Number of pages11
JournalJournal of Cellular Biochemistry
Volume110
Issue number6
DOIs
Publication statusPublished - 15 Aug 2010

Keywords

  • Adipocytes
  • BMP
  • Cancer stem cells
  • Chondrocyte
  • MSC
  • Osteoblast
  • Smad
  • TGF-β
  • Twist
  • Wnt

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{636c163c9ee2426bbdc8be3d17faebf4,
title = "Twist-ing cell fate: Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis",
abstract = "Bone marrow-derived mesenchymal stem cells (MSCs), are multipotent cells that give rise to multiple lineages including osteoblasts, adipocytes, muscle, and fibroblasts. MSCs are useful for clinical applications such as cell therapy because they can be isolated from an individual and expanded for use in tissue repair, as well as other therapeutic applications, without immune rejection. However, one of the key problems in the use of MSCs for these applications is the efficiency of these cells to engraft and fully regenerate damaged tissues. Therefore, to optimize this process, a comprehensive understanding of the key regulators of MSCs self-renewal and maintenance are critical to the success of future cell therapy as well as other clinical applications. The basic helix loop helix transcription factor, Twist, plays a master regulatory role in all of these processes and, therefore, a thorough understanding of the mechanistic insights in the role of Twist in lineage specification/differentiation and tumorigenesis is vital to the success of future clinical applications for the therapeutic use of MSCs. In this article, we highlight the basic mechanisms and signaling pathways that are important to MSC fate, maintenance, and differentiation, as well as the critical role that Twist plays in these processes. In addition, we review the known literature suggesting a critical role for Twist in the generation of cancer stem cells, as this information may contribute to a broader understanding of stem cell biology and stem-cell-based therapeutics.",
keywords = "Adipocytes, BMP, Cancer stem cells, Chondrocyte, MSC, Osteoblast, Smad, TGF-β, Twist, Wnt",
author = "D. Cakouros and Raices, {R. M.} and S. Gronthos and Glackin, {C. A.}",
year = "2010",
month = "8",
day = "15",
doi = "10.1002/jcb.22651",
language = "English",
volume = "110",
pages = "1288--1298",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "6",

}

Twist-ing cell fate : Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis. / Cakouros, D.; Raices, R. M.; Gronthos, S.; Glackin, C. A.

In: Journal of Cellular Biochemistry, Vol. 110, No. 6, 15.08.2010, p. 1288-1298.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Twist-ing cell fate

T2 - Journal of Cellular Biochemistry

AU - Cakouros, D.

AU - Raices, R. M.

AU - Gronthos, S.

AU - Glackin, C. A.

PY - 2010/8/15

Y1 - 2010/8/15

N2 - Bone marrow-derived mesenchymal stem cells (MSCs), are multipotent cells that give rise to multiple lineages including osteoblasts, adipocytes, muscle, and fibroblasts. MSCs are useful for clinical applications such as cell therapy because they can be isolated from an individual and expanded for use in tissue repair, as well as other therapeutic applications, without immune rejection. However, one of the key problems in the use of MSCs for these applications is the efficiency of these cells to engraft and fully regenerate damaged tissues. Therefore, to optimize this process, a comprehensive understanding of the key regulators of MSCs self-renewal and maintenance are critical to the success of future cell therapy as well as other clinical applications. The basic helix loop helix transcription factor, Twist, plays a master regulatory role in all of these processes and, therefore, a thorough understanding of the mechanistic insights in the role of Twist in lineage specification/differentiation and tumorigenesis is vital to the success of future clinical applications for the therapeutic use of MSCs. In this article, we highlight the basic mechanisms and signaling pathways that are important to MSC fate, maintenance, and differentiation, as well as the critical role that Twist plays in these processes. In addition, we review the known literature suggesting a critical role for Twist in the generation of cancer stem cells, as this information may contribute to a broader understanding of stem cell biology and stem-cell-based therapeutics.

AB - Bone marrow-derived mesenchymal stem cells (MSCs), are multipotent cells that give rise to multiple lineages including osteoblasts, adipocytes, muscle, and fibroblasts. MSCs are useful for clinical applications such as cell therapy because they can be isolated from an individual and expanded for use in tissue repair, as well as other therapeutic applications, without immune rejection. However, one of the key problems in the use of MSCs for these applications is the efficiency of these cells to engraft and fully regenerate damaged tissues. Therefore, to optimize this process, a comprehensive understanding of the key regulators of MSCs self-renewal and maintenance are critical to the success of future cell therapy as well as other clinical applications. The basic helix loop helix transcription factor, Twist, plays a master regulatory role in all of these processes and, therefore, a thorough understanding of the mechanistic insights in the role of Twist in lineage specification/differentiation and tumorigenesis is vital to the success of future clinical applications for the therapeutic use of MSCs. In this article, we highlight the basic mechanisms and signaling pathways that are important to MSC fate, maintenance, and differentiation, as well as the critical role that Twist plays in these processes. In addition, we review the known literature suggesting a critical role for Twist in the generation of cancer stem cells, as this information may contribute to a broader understanding of stem cell biology and stem-cell-based therapeutics.

KW - Adipocytes

KW - BMP

KW - Cancer stem cells

KW - Chondrocyte

KW - MSC

KW - Osteoblast

KW - Smad

KW - TGF-β

KW - Twist

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=77955484344&partnerID=8YFLogxK

U2 - 10.1002/jcb.22651

DO - 10.1002/jcb.22651

M3 - Review article

VL - 110

SP - 1288

EP - 1298

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 6

ER -